Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 16Uterine Cervical Neoplasms 5Stomach Neoplasms 5Lung Neoplasms 5Carcinoma, Transitional Cell 5Carcinoma, Hepatocellular 5Squamous Cell Carcinoma of Head and Neck 4Sarcoma 4Prostatic Neoplasms 4Ovarian Neoplasms 4Oropharyngeal Neoplasms 4Esophageal Neoplasms 4Cholangiocarcinoma 4Urinary Bladder Neoplasms 3Thyroid Neoplasms 3Neuroendocrine Tumors 3Neoplasm Metastasis 3Multiple Myeloma 3Lymphoma, Large B-Cell, Diffuse 3Anus Neoplasms 3Testicular Neoplasms 2Solid Tumor 2Pheochromocytoma 2Paraganglioma 2Pancreatic Neoplasms 2Neoplasms 2Mouth Neoplasms 2Melanoma 2Leukemia, Myeloid, Acute 2Laryngeal Neoplasms 2

Interventions

pembrolizumab 25Cisplatin 20Carboplatin 14Paclitaxel 11Radiotherapy 9Radiotherapy, Intensity-Modulated 8Docetaxel 8Cetuximab 8Nivolumab 6cemiplimab 5Radiation 5durvalumab 4atezolizumab 3Taxes 3Surveys and Questionnaires 3Fluorouracil 3Drug Therapy 3Cyclophosphamide 3Blood Specimen Collection 3toripalimab 2olaparib 2fludarabine 2avelumab 2alpha-2'-deoxythioguanosine 2aldesleukin 2Surgical Procedures, Operative 2Standard of Care 2Pemetrexed 2Magnetic Resonance Spectroscopy 2vistusertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × Fluorodeoxyglucose F18 × 1 year × Clear all
NCT03952585 2026-06-01

De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer

National Cancer Institute (NCI)

Phase 2/3 Active not recruiting
384 enrolled 22 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡